India vs South-Eastern Asia: Percentage of bloodstream infection due to methicillin-resistant
India
54.9%
in 2022
South-Eastern Asia
38.1%
in 2022
India rank
8th
South-Eastern Asia rank
11th
Percentage of bloodstream infection due to methicillin-resistant over time
- India
- South-Eastern Asia
How they compare
India currently reports 54.9% against 38.1% in South-Eastern Asia, a difference of 16.8%.
That makes India's figure about 1.4 times South-Eastern Asia's.
Across all 6 years both countries report, India has been ahead every year.
India ranks 8th and South-Eastern Asia ranks 11th of 50 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | South-Eastern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 58.7% | 28.1% | 30.7% | India |
| 2020s | 58.4% | 35.6% | 22.8% | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, India or South-Eastern Asia?
- India, at 54.9% against 38.1% in South-Eastern Asia as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between India and South-Eastern Asia?
- 16.8%, with India ahead.
- How many years of comparable data are there for India and South-Eastern Asia?
- 6 years are reported by both, from 2017 to 2022.
- How do India and South-Eastern Asia rank globally for percentage of bloodstream infection due to methicillin-resistant?
- India ranks 8th and South-Eastern Asia ranks 11th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.